| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9117574 | Metabolism | 2005 | 9 Pages |
Abstract
Pioglitazone increased subcutaneous body fat, but not visceral fat. There was no measurable effect on energy expenditure or hunger/satiety. In contrast to the placebo-treated patient with diabetes, weight gain occurs in the face of falling hemoglobin A1c and triglyceride levels.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Steven R. Smith, Lilian de Jonge, Julia Volaufova, Yinmei Li, Hui Xie, George A. Bray,